Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alliance Global (AGBL) is a prominent biomedical gateway and distributor serving the Middle East, Africa, and Central Asia. The company focuses on delivering advanced technologies in the fields of molecular diagnostics, life science research, and clinical genomics. AGBL acts as a critical link between global technology manufacturers and local healthcare and research institutions, providing not only products but also extensive technical support and training. Their portfolio includes solutions for DNA sequencing, PCR, and cellular analysis, supporting applications in oncology, infectious disease, and personalized medicine. The group operates through a network of regional offices, ensuring localized service and logistics for complex laboratory equipment and reagents. By facilitating access to cutting-edge genomic tools, AGBL plays a vital role in the expansion of precision medicine across emerging markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alliance Global FZ.